Bidirectionally H<sub>2</sub>O<sub>2</sub>-suppliable and antioxidant-consumable copper peroxide nanoparticles for photochemodynamic immunotherapy.

Zhao, Yanan; Li, Ting; Yao, Yao; Xue, Shujuan; Xu, Tao; Mi, Shuqi; Li, Dazhao; Tang, Xiaolei et al. · Biomaterials · 2026

basic_science · Level V

Where this comes from

Abstract

Reactive oxygen species (ROS)-based antitumor compounds show great promise in cancer treatments such as chemodynamic therapy (CDT) and photodynamic therapy (PDT), but are severely restricted by both endogenous antioxidants and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>). Here, we synthesize bidirectionally H<sub>2</sub>O<sub>2</sub>-suppliable and antioxidant-consumable copper peroxide (CuO<sub>2</sub>) nanoparticles for CDT/PDT-synergized immunotherapy against aggressive triple-negative breast cancers (TNBCs). The CuO<sub>2</sub> nanoparticles are established to afford pH-responsive decomposition into H<sub>2</sub>O<sub>2</sub> and Cu<sup>2+</sup>, followed by the reduction into Cu<sup>+</sup> by glutathione and subsequent catalysis reaction of H<sub>2</sub>O<sub>2</sub> into highly reactive ·OH, thus yielding CDT-mediated cell injury. Meanwhile, the glutathione consumption from the nanoparticles attenuates their ROS scavenging to promote singlet oxygen generation of co-assembled indocyanine green upon light exposure, thereby amplifying PDT-based cell damage. Moreover, the dully enhanced CDT/PDT damages of the nanoparticles provoke potent immunogenic cell death that further synergizes with immune checkpoint inhibitor via relieving indoleamine 2,3-dioxygenase 1-mediated immunosuppression, thus amplifying immunotherapeutic efficacy against primary, distant and metastatic TNBCs. This work provides valuable insights into nanomedicines for synergistic cancer therapy.

Medical subject headings